Simons M - Search Results

1

Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.

Laham RJ, Chronos NA, Pike M, Leimbach ME, Udelson JE, Pearlman JD, Pettigrew RI, Whitehouse MJ, Yoshizawa C, Simons M. Laham RJ, et al. Among authors: simons m. J Am Coll Cardiol. 2000 Dec;36(7):2132-9. doi: 10.1016/s0735-1097(00)00988-8. J Am Coll Cardiol. 2000. PMID: 11127452 Free article. Clinical Trial.

2

Assessment of relative sensitivities of noninvasive tests for cardiac amyloidosis in documented cardiac amyloidosis.

Simons M, Isner JM. Simons M, et al. Am J Cardiol. 1992 Feb 1;69(4):425-7. doi: 10.1016/0002-9149(92)90250-3. Am J Cardiol. 1992. PMID: 1734663 No abstract available.

3

Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis.

Pearlman JD, Hibberd MG, Chuang ML, Harada K, Lopez JJ, Gladstone SR, Friedman M, Sellke FW, Simons M. Pearlman JD, et al. Among authors: simons m. Nat Med. 1995 Oct;1(10):1085-9. doi: 10.1038/nm1095-1085. Nat Med. 1995. PMID: 7489368

4

Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts.

Harada K, Grossman W, Friedman M, Edelman ER, Prasad PV, Keighley CS, Manning WJ, Sellke FW, Simons M. Harada K, et al. Among authors: simons m. J Clin Invest. 1994 Aug;94(2):623-30. doi: 10.1172/JCI117378. J Clin Invest. 1994. PMID: 7518840 Free PMC article.

5

Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation.

Sellke FW, Wang SY, Friedman M, Harada K, Edelman ER, Grossman W, Simons M. Sellke FW, et al. Among authors: simons m. Am J Physiol. 1994 Oct;267(4 Pt 2):H1303-11. doi: 10.1152/ajpheart.1994.267.4.H1303. Am J Physiol. 1994. PMID: 7943375

6

The role of clinical data in interpretation of perfusion images.

Simons M, Parker JA, Udelson JE, Gervino EV. Simons M, et al. J Nucl Med. 1994 Apr;35(4):740-1. J Nucl Med. 1994. PMID: 8151406 Free article. No abstract available.

7

Pericardial effusion in patients with cancer: outcome with contemporary management strategies.

Laham RJ, Cohen DJ, Kuntz RE, Baim DS, Lorell BH, Simons M. Laham RJ, et al. Among authors: simons m. Heart. 1996 Jan;75(1):67-71. doi: 10.1136/hrt.75.1.67. Heart. 1996. PMID: 8624876 Free PMC article.

8

Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia.

Sellke FW, Li J, Stamler A, Lopez JJ, Thomas KA, Simons M. Sellke FW, et al. Among authors: simons m. Surgery. 1996 Aug;120(2):182-8. doi: 10.1016/s0039-6060(96)80286-8. Surgery. 1996. PMID: 8751581

9

Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium.

Sellke FW, Wang SY, Stamler A, Lopez JJ, Li J, Li J, Simons M. Sellke FW, et al. Among authors: simons m. Am J Physiol. 1996 Aug;271(2 Pt 2):H713-20. doi: 10.1152/ajpheart.1996.271.2.H713. Am J Physiol. 1996. PMID: 8770115

10

Local perivascular administration of basic fibroblast growth factor: drug delivery and toxicological evaluation.

Lopez JJ, Edelman ER, Stamler A, Morgan JP, Sellke FW, Simons M. Lopez JJ, et al. Among authors: simons m. Drug Metab Dispos. 1996 Aug;24(8):922-4. Drug Metab Dispos. 1996. PMID: 8869829 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,546 results

Search Page

Filters